Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neostigmine versus conventional treatment for post-dural puncture headache
PACTR201510001299332Completed
- Sponsor
- Beni-Suef University Hospital
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of neostigmine in post-dural puncture headache (PDPH) (2 arms), sponsored by Beni-Suef University Hospital. Primary endpoint: Treatment of post-dural puncture headache. Started Mar 2014; status: completed.
02
Drugs
neostigmine
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on PACTR201510001299332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201510001299332.